NASDAQ: MIST
Milestone Pharmaceuticals Inc Stock Ownership - Who owns Milestone Pharmaceuticals?

Insider buying vs selling

Have Milestone Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph OlivetoPresident and CEO2026-04-1636,500$2.26
$82.49kSell
Jeffrey Edward NelsonChief Operating Officer2026-01-2612,245$1.93
$23.63kSell
Amit HasijaCFO EVP of Corp. Development2026-01-2612,245$1.93
$23.63kSell
David BharuchaChief Medical Officer2026-01-2612,245$1.93
$23.63kSell
Joseph OlivetoPresident and CEO2026-01-2634,523$1.93
$66.63kSell
Lorenz MullerChief Commercial Officer2026-01-2611,180$1.93
$21.58kSell
Joseph OlivetoPresident and CEO2026-01-0843,000$2.25
$96.75kSell
Joseph OlivetoPresident and CEO2026-01-07500$2.25
$1.13kSell
Jeffrey Edward NelsonChief Operating Officer2025-12-1558,007$2.32
$134.58kSell
Amit HasijaCFO EVP of Corp. Development2025-12-1558,007$2.32
$134.58kSell

1 of 2

MIST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIST insiders and whales buy or sell their stock.

MIST Shareholders

What type of owners hold Milestone Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP6.43%7,571,204$14.31MInsider
Propel Bio Management LLC3.50%4,118,321$7.78MInstitution
Adage Capital Partners GP LLC2.39%2,810,037$5.31MInstitution
Rtw Investments LP2.13%2,506,102$4.74MInstitution
Holdings A. Novo2.07%2,434,470$4.60MInsider
De Solidarite Des Travailleurs Du Quebec Fonds1.92%2,254,920$4.26MInsider
Marshall Wace LLP1.41%1,656,821$3.13MInstitution
Two Sigma Investments LP1.29%1,514,461$2.86MInstitution
Simplify Asset Management Inc1.28%1,506,405$2.85MInstitution
Jane Street Group LLC0.93%1,093,230$2.07MInstitution

1 of 3

MIST vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIST22.52%11.49%Net SellingNet Selling
NKTX61.06%38.94%Net Selling
HRTX55.55%44.45%Net Buying
CAMP59.53%40.47%Net Buying
ALEC64.04%35.96%Net SellingNet Selling

Milestone Pharmaceuticals Stock Ownership FAQ

Who owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals (NASDAQ: MIST) is owned by 22.52% institutional shareholders, 11.49% Milestone Pharmaceuticals insiders, and 65.99% retail investors. Rtw Investments LP is the largest individual Milestone Pharmaceuticals shareholder, owning 7.57M shares representing 6.43% of the company. Rtw Investments LP's Milestone Pharmaceuticals shares are currently valued at $14.54M.

If you're new to stock investing, here's how to buy Milestone Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.